SPARK Europe Webinar Series | Business models of life science companies - How to select the right one? Tools and thoughts
Sebastian Soidinsalo | 7 December 2022 | 4-5 pm (CET)
Kit? Service? Licensing? Inhouse? Outsourced? Risk-sharing? Going alone or partner? Distributors? VC or other forms of financing?
How to organize a life science company to create the most value out of a technology and increase the competitive advantage? Rarely there is only one approach – a careful analysis of alternatives and internal competencies and resources should guide decisions on how to organize the business. Tools like the business model canvas and the lean canvas, can be invaluable in learning to ask the right questions in the beginning of the innovation journey and later when corporate strategy is planned.
In this SPARK Europe Webinar, Sebastian Soidinsalo will present the tools of the trade in conceptualizing and polishing life science business models. Sebastian brings a decade of experience in startups and university innovation with focus on drug discovery, enabling biotechnologies and In Vitro Diagnostics. Sebastian holds a Master’s in Drug Discovery and a Master’s in Business Administration and Bioentrepreneurship.
Registration:
Register here! Registration to the webinar is required in advance. Please register on 6 December 2022 at the latest. Later registrations’ access cannot be guaranteed. There are limited number of places available and they will be filled in the order of registration.
This webinar is organized by SPARK Finland.
The webinars are open for all SPARKees, SPARK mentors, and students and staff of SPARK associated organizations.
Contact:
Katharina Clausnitzer
katharina.clausnitzer@bih-charite.de
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
